• Patients
  • We reviewed the current studies that evaluated therapeutic role of a relatively new immunosuppressive drug "rituximab" in reducing proteinuria and reduction of relapse rate in less than 16 year old patients with non-responsive or steroid dependent nephrotic syndrome. (jpediatricsreview.com)
  • In Steroid Dependent Nephrotic syndrome patients, the overall standard mean differences of mean number of relapses 12 mo after treatment in pooled four studies (56 cases) was 2.63 (2.03, 3.24). (jpediatricsreview.com)